Glaxo Wellcome

Organisation

Trials

NCT00009061
Phase 3, Status unknown, 624 people, 31 Aug 2001
NCT00008554
Phase 3, Status unknown, 210 people, 31 Aug 2001
NCT00005764
Phase 4, Completed, 100 people, 31 Aug 2001
NCT00005106
Phase 4, Completed, 230 people, 31 Aug 2001
NCT00005017
Phase 4, Status unknown, 300 people, 31 Aug 2001
NCT00004981
Phase 3, Status unknown, 230 people, 31 Aug 2001
NCT00004852
Phase 2, Completed, 31 Aug 2001
NCT00004585
Phase 4, Completed, 40 people, 31 Aug 2001
NCT00002442
Phase 2, Completed, 31 Aug 2001
NCT00002436
Phase 3, Completed, 325 people, 31 Aug 2001
NCT00002423
Phase 2, Completed, 100 people, 31 Aug 2001
NCT00002409
Phase 3, Completed, 200 people, 31 Aug 2001
NCT00002391
Phase 3, Completed, 31 Aug 2001
NCT00002389
Phase 3, Completed, 210 people, 31 Aug 2001
NCT00002320
Phase 3, Completed, 320 people, 31 Aug 2001
NCT00002245
Phase 3, Completed, 31 Aug 2001
NCT00002234
Collaborator, Phase 2, Completed, 25 people, 31 Aug 2001
NCT00002233
Phase 2, Completed, 30 people, 31 Aug 2001
NCT00002199
Phase 3, Completed, 550 people, 31 Aug 2001
NCT00002195
Phase 3, Completed, 290 people, 31 Aug 2001